Rational design of potent small molecule SMARCA2/A4(BRM/BRG1) degraders acting via the recruitment of FBXO22

preprint OA: closed
Full text JSON View at publisher
Full text 20,262 characters · extracted from preprint-html · click to expand
Rational design of potent small molecule SMARCA2/A4(BRM/BRG1) degraders acting via the recruitment of FBXO22 | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Rational design of potent small molecule SMARCA2/A4(BRM/BRG1) degraders acting via the recruitment of FBXO22 Robert Yauch, Elisia Villemure, Tom Januario, Mingshuo Zeng, Hanna Budayeva, and 16 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6033426/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 03 Nov, 2025 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Abstract Target-anchored monovalent degraders are more drug-like than their bivalent counterparts, Proteolysis Targeting Chimeras (PROTACs), while offering greater target specificity control than the E3 ligase-anchored monovalent degraders, also known as molecular glues. However, their discovery has typically been serendipitous, and the rules governing their identification remain unclear. This study focused on the intentional discovery of SMARCA2/A4 monovalent degraders using a library based on SMARCA2/A4 bromodomain-binding ligands. Compound G-6599 emerged as a lead candidate, showing exceptional degradation potency and specificity for SMARCA2/A4. Mechanistic studies revealed that G-6599 operates through the ubiquitin-proteasome pathway and the E3 ligase FBXO22. G-6599 was shown to promote ternary complex formation between SMARCA2 and FBXO22 involving covalent conjugation to a cysteine residue on the latter. Unlike other recently identified FBXO22-dependent degraders, it does not require biotransformation. The selective degradation ability of G-6599, along with its unique mechanism, highlights the therapeutic potential of target-anchored monovalent degraders. Biological sciences/Chemical biology/Small molecules Biological sciences/Chemical biology/Mechanism of action Full Text Additional Declarations Yes there is potential Competing Interest. Authors are employees of Genentech and/or hold stock in Roche. Supplementary Files SupplementaryTable1.xlsx Supplementary Table Dataset 1 SupplementaryTable2.xlsx Supplementary Table Dataset 2 SupplementaryTable3.xlsx Supplementary Table Dataset 3 SupplementaryTable4.xlsx Supplementary Table Dataset 4 SupplementaryTable5.xlsx Supplementary Table Dataset 5 SupplementaryTable6.xlsx Supplementary Table Dataset 6 SupplementaryTable7.xlsx Supplementary Table Dataset 7 SupportingInformationRationaldesignofpotentsmallmoleculeSMARCA2A4BRMBRG1degradersactingviarecruitmentofFBXO22.pdf Supportive Information Cite Share Download PDF Status: Published Journal Publication published 03 Nov, 2025 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6033426","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":420943131,"identity":"2311264e-c590-4499-8954-772f2673f0fc","order_by":0,"name":"Robert Yauch","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAvklEQVRIiWNgGAWjYBACAwYeMJ3AT7oWyQaStRgcIFaLOXvvMYmfbXZ5xucXH3vwgcFOTpeQdZY959Ike9uSi81uPEs3nMGQbGxGyDqDGzlmErxtBxK33ThjJs3DAGQQo0XyL1DL5hnnv0n/IVaLNMiWDfw9bNIMxGgB+iXZWuZccuKMG2xmkj0GRPgFGGIHb74ps0vs7z/8TOJHhZ0cQS1AwCIBpiQSQO4krBwEmD+AKX4iTB8Fo2AUjIKRCQBcKUUOFaSy9AAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0001-9478-6283","institution":"Genentech, Inc.","correspondingAuthor":true,"prefix":"","firstName":"Robert","middleName":"","lastName":"Yauch","suffix":""},{"id":420943132,"identity":"9380cd9d-86e8-4048-8043-a9fa14e5c619","order_by":1,"name":"Elisia Villemure","email":"","orcid":"","institution":"Genentech, Inc.","correspondingAuthor":false,"prefix":"","firstName":"Elisia","middleName":"","lastName":"Villemure","suffix":""},{"id":420943133,"identity":"d669be1b-4b6d-4503-a830-272c3ad6d199","order_by":2,"name":"Tom Januario","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Tom","middleName":"","lastName":"Januario","suffix":""},{"id":420943134,"identity":"ce533104-df26-44f9-a36f-fecb4516d85c","order_by":3,"name":"Mingshuo Zeng","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Mingshuo","middleName":"","lastName":"Zeng","suffix":""},{"id":420943135,"identity":"d7fe5489-538a-4434-9130-6b2235440336","order_by":4,"name":"Hanna Budayeva","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Hanna","middleName":"","lastName":"Budayeva","suffix":""},{"id":420943136,"identity":"cc8189d9-9ef3-47aa-8ae6-ae9bfa08f8d5","order_by":5,"name":"Benjamin Walters","email":"","orcid":"https://orcid.org/0000-0001-5400-0696","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Benjamin","middleName":"","lastName":"Walters","suffix":""},{"id":420943137,"identity":"bb0324c5-53c2-4146-b87f-dc8401ea8b24","order_by":6,"name":"Aaron Lictao","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Aaron","middleName":"","lastName":"Lictao","suffix":""},{"id":420943138,"identity":"97fc25a1-e012-4d42-8af7-1172c9c65bf3","order_by":7,"name":"Ke Sherry Li","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Ke","middleName":"Sherry","lastName":"Li","suffix":""},{"id":420943139,"identity":"0b7c566f-13da-4dff-92d9-3a5b508dea1f","order_by":8,"name":"Xiaofen Ye","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Xiaofen","middleName":"","lastName":"Ye","suffix":""},{"id":420943140,"identity":"ac1aaa29-f57f-4904-9454-66b2039a4718","order_by":9,"name":"Caroline Gilchrist","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Caroline","middleName":"","lastName":"Gilchrist","suffix":""},{"id":420943141,"identity":"c3c2db76-52be-4909-8283-6aa0da1ba403","order_by":10,"name":"Bridget Hoag","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Bridget","middleName":"","lastName":"Hoag","suffix":""},{"id":420943142,"identity":"e89a8da9-1daa-4d08-800b-27db5de0a55e","order_by":11,"name":"Nicholas Endres","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Nicholas","middleName":"","lastName":"Endres","suffix":""},{"id":420943143,"identity":"85ed2ec8-6f6b-4b7d-a174-ad1b5d7d4038","order_by":12,"name":"Peter Hsu","email":"","orcid":"","institution":"Genentech, Inc.","correspondingAuthor":false,"prefix":"","firstName":"Peter","middleName":"","lastName":"Hsu","suffix":""},{"id":420943144,"identity":"34508543-971c-4f2b-9b3d-37fd434469a5","order_by":13,"name":"John Chan","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"John","middleName":"","lastName":"Chan","suffix":""},{"id":420943145,"identity":"ee69f5ed-e015-4917-ae47-a89888b63e0e","order_by":14,"name":"Tommy Cheung","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Tommy","middleName":"","lastName":"Cheung","suffix":""},{"id":420943146,"identity":"13d9ebe6-6d76-4c29-a3d6-6b9865acca05","order_by":15,"name":"Michael Costa","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Michael","middleName":"","lastName":"Costa","suffix":""},{"id":420943147,"identity":"6ca7c26d-4a9d-4647-9486-e56fe07a55c9","order_by":16,"name":"Jean-Philippe Fortin","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Jean-Philippe","middleName":"","lastName":"Fortin","suffix":""},{"id":420943148,"identity":"6ad710f5-ed0e-4546-8ad9-8f6353d8ed1a","order_by":17,"name":"Noriko Ishisoko","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Noriko","middleName":"","lastName":"Ishisoko","suffix":""},{"id":420943149,"identity":"cf3e697d-7aa0-4571-a29a-fcc4d8a30162","order_by":18,"name":"Brett Babin","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Brett","middleName":"","lastName":"Babin","suffix":""},{"id":420943150,"identity":"dad2cae3-ad15-40a8-a9ba-c394b59e2fcf","order_by":19,"name":"Joyce Liu","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Joyce","middleName":"","lastName":"Liu","suffix":""},{"id":420943151,"identity":"846a03fd-060c-48f6-bcbe-25cad7350071","order_by":20,"name":"Joachim Rudolph","email":"","orcid":"","institution":"Genentech","correspondingAuthor":false,"prefix":"","firstName":"Joachim","middleName":"","lastName":"Rudolph","suffix":""}],"badges":[],"createdAt":"2025-02-14 22:25:24","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6033426/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6033426/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41467-025-64669-4","type":"published","date":"2025-11-03T05:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":95089675,"identity":"e5593f90-0aa5-40cf-beaa-036e4bc9db17","added_by":"auto","created_at":"2025-11-04 08:07:48","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2213057,"visible":true,"origin":"","legend":"Article File","description":"","filename":"RationaldesignofpotentsmallmoleculeSMARCA2A4BRMBRG1degradersactingviarecruitmentofFBXO22Manuscriptandfigurescombined2112025.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1_covered_0cc01c58-46c6-46e3-9d9e-0aa8e8e0a8d3.pdf"},{"id":78107809,"identity":"61c4926f-a425-4382-8f4a-0d4940744ce6","added_by":"auto","created_at":"2025-03-10 04:09:53","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":78094,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table Dataset 1\u003c/p\u003e","description":"","filename":"SupplementaryTable1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/ce53cca9a7e502c34d06177a.xlsx"},{"id":78107811,"identity":"0ae2e19e-72de-44e2-a963-1ce271ac1b5e","added_by":"auto","created_at":"2025-03-10 04:09:53","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":1677226,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table Dataset 2\u003c/p\u003e","description":"","filename":"SupplementaryTable2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/2ae7064d96ee0be5a9e85b17.xlsx"},{"id":78108015,"identity":"36d3bc63-9c15-458b-a096-9ea991feff65","added_by":"auto","created_at":"2025-03-10 04:17:53","extension":"xlsx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":1517313,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table Dataset 3\u003c/p\u003e","description":"","filename":"SupplementaryTable3.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/d2fd478cfe24057d19d44802.xlsx"},{"id":78107807,"identity":"ef08ea93-9aac-491c-90c9-147474e6547f","added_by":"auto","created_at":"2025-03-10 04:09:53","extension":"xlsx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":57439,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table Dataset 4\u003c/p\u003e","description":"","filename":"SupplementaryTable4.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/80b31f4f66b21e84d32482a7.xlsx"},{"id":78107810,"identity":"db85bed6-73d0-4655-af5c-c0fff007f4e3","added_by":"auto","created_at":"2025-03-10 04:09:53","extension":"xlsx","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":442729,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table Dataset 5\u003c/p\u003e","description":"","filename":"SupplementaryTable5.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/9fc12130bdc0025442f88a28.xlsx"},{"id":78107805,"identity":"86459d15-94d2-4d4a-bfa0-270a480847f9","added_by":"auto","created_at":"2025-03-10 04:09:53","extension":"xlsx","order_by":6,"title":"","display":"","copyAsset":false,"role":"supplement","size":67896,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table Dataset 6\u003c/p\u003e","description":"","filename":"SupplementaryTable6.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/6b213b901427584e9441eeb5.xlsx"},{"id":78107808,"identity":"3e9399a3-177a-4fb5-9016-15d9f038b2d0","added_by":"auto","created_at":"2025-03-10 04:09:53","extension":"xlsx","order_by":7,"title":"","display":"","copyAsset":false,"role":"supplement","size":10122,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table Dataset 7\u003c/p\u003e","description":"","filename":"SupplementaryTable7.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/0a86db6eadef660264982696.xlsx"},{"id":78107813,"identity":"3a33cd3a-989f-4b54-b465-9ed82dba0203","added_by":"auto","created_at":"2025-03-10 04:09:53","extension":"pdf","order_by":8,"title":"","display":"","copyAsset":false,"role":"supplement","size":4469859,"visible":true,"origin":"","legend":"\u003cp\u003eSupportive Information\u003c/p\u003e","description":"","filename":"SupportingInformationRationaldesignofpotentsmallmoleculeSMARCA2A4BRMBRG1degradersactingviarecruitmentofFBXO22.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6033426/v1/1d07bd267cc2b0a3a05494d1.pdf"}],"financialInterests":"\u003cb\u003eYes\u003c/b\u003e there is potential Competing Interest.\nAuthors are employees of Genentech and/or hold stock in Roche.","formattedTitle":"Rational design of potent small molecule SMARCA2/A4(BRM/BRG1) degraders acting via the recruitment of FBXO22","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-6033426/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6033426/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Target-anchored monovalent degraders are more drug-like than their bivalent counterparts,\r\nProteolysis Targeting Chimeras (PROTACs), while offering greater target specificity control than\r\nthe E3 ligase-anchored monovalent degraders, also known as molecular glues. However, their\r\ndiscovery has typically been serendipitous, and the rules governing their identification remain\r\nunclear. This study focused on the intentional discovery of SMARCA2/A4 monovalent degraders\r\nusing a library based on SMARCA2/A4 bromodomain-binding ligands. Compound G-6599\r\nemerged as a lead candidate, showing exceptional degradation potency and specificity for\r\nSMARCA2/A4. Mechanistic studies revealed that G-6599 operates through the\r\nubiquitin-proteasome pathway and the E3 ligase FBXO22. G-6599 was shown to promote\r\nternary complex formation between SMARCA2 and FBXO22 involving covalent conjugation to\r\na cysteine residue on the latter. Unlike other recently identified FBXO22-dependent degraders, it\r\ndoes not require biotransformation. The selective degradation ability of G-6599, along with its\r\nunique mechanism, highlights the therapeutic potential of target-anchored monovalent degraders.","manuscriptTitle":"Rational design of potent small molecule SMARCA2/A4(BRM/BRG1) degraders acting via the recruitment of FBXO22","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-03-10 04:09:48","doi":"10.21203/rs.3.rs-6033426/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"3e808724-5b7c-41fb-9c8f-cfb34ba0e1a1","owner":[],"postedDate":"March 10th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":44871925,"name":"Biological sciences/Chemical biology/Small molecules"},{"id":44871926,"name":"Biological sciences/Chemical biology/Mechanism of action"}],"tags":[],"updatedAt":"2025-11-04T08:07:38+00:00","versionOfRecord":{"articleIdentity":"rs-6033426","link":"https://doi.org/10.1038/s41467-025-64669-4","journal":{"identity":"nature-communications","isVorOnly":false,"title":"Nature Communications"},"publishedOn":"2025-11-03 05:00:00","publishedOnDateReadable":"November 3rd, 2025"},"versionCreatedAt":"2025-03-10 04:09:48","video":"","vorDoi":"10.1038/s41467-025-64669-4","vorDoiUrl":"https://doi.org/10.1038/s41467-025-64669-4","workflowStages":[]},"version":"v1","identity":"rs-6033426","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6033426","identity":"rs-6033426","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00